Obinutuzumab Can Be Administered as a 90-minute Short Duration Infusion in Patients with Previously Untreated Follicular Lymphoma: GAZELLE End of Induction Analysis

  1. Canales, M.A.
  2. Buchholz, T.A.
  3. Bortolini, J.A.P.
  4. Fogliatto, L.M.
  5. Ishikawa, T.
  6. Izutsu, K.
  7. Salar, A.
  8. Sharman, J.P.
  9. Klingbiel, D.
  10. Pokala, S.
  11. Vorozheikina, E.
  12. Trask, P.
  13. Parreira, J.
  14. Hübel, K.
Journal:
HemaSphere

ISSN: 2572-9241

Year of publication: 2023

Volume: 7

Issue: 4

Pages: E860

Type: Letter

DOI: 10.1097/HS9.0000000000000860 GOOGLE SCHOLAR lock_openOpen access editor